<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Wearable</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Kanaph, Imbiologics to kick off 2026 Korea biotech, med-tech IPOs </title>
      <description>
        <![CDATA[Two biotech and three med-tech companies are slated for Kosdaq debuts this month, signaling a potential rebound for Korea financings in 2026. Kanaph Therapeutics Inc. will open with a ₩40 billion (US$26.99 million) raise and Imbiologics Corp. will debut with ₩52 billion. Additionally, Mezoo Co. Ltd., Cosmo Robotics Co. Ltd. and Recensmedical Inc. will launch IPOs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729714</guid>
      <pubDate>Tue, 17 Mar 2026 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729714-kanaph-imbiologics-to-kick-off-2026-korea-biotech-med-tech-ipos</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2026/Imbiologics-CEO-Ha-Gyong-sik-hero-03-13-26.webp?t=1773432672" type="image/jpeg" medium="image" fileSize="633322">
        <media:title type="plain">Ha Gyong sik giving a presentation</media:title>
        <media:description type="plain">Ha Gyong-sik, CEO, Imbiologics</media:description>
      </media:content>
    </item>
    <item>
      <title>Kanaph, Imbiologics to kick off 2026 Korea biotech, med-tech IPOs </title>
      <description>
        <![CDATA[Two biotech and three med-tech companies are slated for Kosdaq debuts this month, signaling a potential rebound for Korea financings in 2026. Kanaph Therapeutics Inc. will open with a ₩40 billion (US$26.99 million) raise and Imbiologics Corp. will debut with ₩52 billion. Additionally, Mezoo Co. Ltd., Cosmo Robotics Co. Ltd. and Recensmedical Inc. will launch IPOs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729495</guid>
      <pubDate>Fri, 13 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729495-kanaph-imbiologics-to-kick-off-2026-korea-biotech-med-tech-ipos</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2026/Imbiologics-CEO-Ha-Gyong-sik-hero-03-13-26.webp?t=1773432672" type="image/jpeg" medium="image" fileSize="633322">
        <media:title type="plain">Ha Gyong sik giving a presentation</media:title>
        <media:description type="plain">Ha Gyong-sik, CEO, Imbiologics</media:description>
      </media:content>
    </item>
    <item>
      <title>Researchers develop Revoice for stroke patients</title>
      <description>
        <![CDATA[Researchers have developed an AI-based wearable device, called Revoice, to help individuals communicate effectively after a stroke. The system, worn around the neck, uses sensors to capture carotid pulse signals and subtle vibrations from throat muscles to reconstruct intended words and sentences in real time, potentially transforming the lives of stroke patients living with dysarthria.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728087</guid>
      <pubDate>Fri, 23 Jan 2026 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728087-researchers-develop-revoice-for-stroke-patients</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2023/ai_stroke-8sept23.webp?t=1694207919" type="image/jpeg" medium="image" fileSize="395159">
        <media:title type="plain">Brain with stroke illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>FDA tackles BP wearables in new draft guidance</title>
      <description>
        <![CDATA[The FDA’s Center for Devices and Radiological Health posted two important guidances just in the first week of the new year. The agency seems determined to sustain that pace with a new draft guidance for cuffless blood pressure monitors, apparently in response to sales of unauthorized over-the-counter devices for this indication.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728084</guid>
      <pubDate>Fri, 23 Jan 2026 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728084-fda-tackles-bp-wearables-in-new-draft-guidance</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/FDA-headquarters-signage.webp?t=1762209624" type="image/jpeg" medium="image" fileSize="1105340">
        <media:title type="plain">FDA headquarters signage</media:title>
        <media:description type="plain">Credit: Tada Images - stock.adobe.com</media:description>
      </media:content>
    </item>
    <item>
      <title>Naox secures FDA clearance for EEG earbuds</title>
      <description>
        <![CDATA[Naox Technologies SAS secured U.S. FDA 510(k) clearance for Naox Link, its in-ear electroencephalography (EEG) device for clinical use both at home and in health care settings. Naox Link is a pair of earbuds the company hopes will transform how the brain activity is monitored, helping diagnose and track a number of conditions affecting the brain.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727574</guid>
      <pubDate>Tue, 06 Jan 2026 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727574-naox-secures-fda-clearance-for-eeg-earbuds</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2026/Naox-Link-6jan26.webp?t=1767740518" type="image/jpeg" medium="image" fileSize="69636">
        <media:title type="plain">Naox Link</media:title>
        <media:description type="plain">Naox Link. Credit: Naox Technologies SaS</media:description>
      </media:content>
    </item>
    <item>
      <title>Kestra follows IPO with $138M upsized offering</title>
      <description>
        <![CDATA[After raising more than twice as much as expected in its March IPO, Kestra Medical Technologies Inc. appears poised to repeat its success with an upsized secondary offering as well. The Kirkland, Wash.-based company initially planned to offer 5.5 million shares in its second pass at the market but increased the number of shares to 6 million two days later when it set the price at $23 per share. The projected gross proceeds of $138 million provide a nice addition to the $232 million raised nine months ago.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726457</guid>
      <pubDate>Wed, 03 Dec 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726457-kestra-follows-ipo-with-138m-upsized-offering</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/kestra-1feb25.webp?t=1762811729" type="image/jpeg" medium="image" fileSize="241499">
        <media:title type="plain">Kestra</media:title>
        <media:description type="plain">Kestra Assure wearable cardioverter defibrillator. Credit: Kestra</media:description>
      </media:content>
    </item>
    <item>
      <title>Analysts see tide turning toward Masimo in Apple patent war</title>
      <description>
        <![CDATA[A jury has returned a verdict of infringement against Apple Inc., as part of a series of patent disputes with Masimo Corp., producing a damages award of $634 million which is seen in some quarters as an indicator that Masimo has the momentum against Apple.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726201</guid>
      <pubDate>Tue, 18 Nov 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726201-analysts-see-tide-turning-toward-masimo-in-apple-patent-war</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/apple-watch-pulseox-14aut25.webp?t=1755209042" type="image/jpeg" medium="image" fileSize="134041">
        <media:title type="plain">Apple Watch pulseox</media:title>
        <media:description type="plain">Credit: Kaboompics.com</media:description>
      </media:content>
    </item>
    <item>
      <title>Mode Sensors hydration monitoring system receives FDA clearance</title>
      <description>
        <![CDATA[Mode Sensors AS received U.S. FDA 510(k) clearance for its Re:Balans hydration monitoring system. The wearable patch sensor allows for the continuous monitoring of body hydration to detect fluid imbalances using thoracic bioimpedance technology to deliver automatic, accurate data to help physicians in fluid management.]]>
      </description>
      <guid>http://www.bioworld.com/articles/725174</guid>
      <pubDate>Fri, 24 Oct 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/725174-mode-sensors-hydration-monitoring-system-receives-fda-clearance</link>
      <media:content url="https://www.bioworld.com/ext/resources/2025/ReBalans-hydration-monitoring-patch-24oct25.webp?t=1761334807" type="image/jpeg" medium="image" fileSize="459164">
        <media:title type="plain">ReBalans hydration monitoring patch</media:title>
        <media:description type="plain">ReBalans hydration monitoring patch. Credit: Mode Sensors</media:description>
      </media:content>
    </item>
    <item>
      <title>Alimetry brings first wearable gut diagnostic to market</title>
      <description>
        <![CDATA[Alimetry Ltd. is making waves far beyond its home market with its first-in-class wearable Gastric Alimetry device that measures gut function – an area long considered a black box in gastroenterology.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724109</guid>
      <pubDate>Wed, 17 Sep 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724109-alimetry-brings-first-wearable-gut-diagnostic-to-market</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Gastric-Alimetry-device-17sept25.webp?t=1758133480" type="image/jpeg" medium="image" fileSize="377795">
        <media:title type="plain">Gastric Alimetry</media:title>
        <media:description type="plain">The Gastric Alimetry device is like an ECG for the gut. Credit: Alimetry</media:description>
      </media:content>
    </item>
    <item>
      <title>Apple reintroduces pulseox via software update</title>
      <description>
        <![CDATA[Some Apple Watch users will be able to monitor their blood oxygen levels through their iPhone, thanks to a software update the company planned to issue Aug. 14. The Cupertino, Calif.-based company pulled the feature from its watches in the U.S. in 2024, following a patent dispute with Masimo Corp., of Irvine, Calif., that threatened an import ban.]]>
      </description>
      <guid>http://www.bioworld.com/articles/722858</guid>
      <pubDate>Thu, 14 Aug 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/722858-apple-reintroduces-pulseox-via-software-update</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/apple-watch-pulseox-14aut25.webp?t=1755209042" type="image/jpeg" medium="image" fileSize="134041">
        <media:title type="plain">Apple Watch pulseox</media:title>
        <media:description type="plain">Credit: Kaboompics.com</media:description>
      </media:content>
    </item>
    <item>
      <title>Trinity unveils AI-powered CGM+ biosensor</title>
      <description>
        <![CDATA[Trinity Biotech plc recently unveiled CGM+, an AI-native, wearable biosensor that goes beyond traditional continuous glucose monitors and tracks glucose levels, cardiovascular activity and body temperature at the same time. The company believes that as precision medicine becomes central to health care, especially with the collection of real-time data, CGM+ will become a critical enabler of AI-based diagnostics, behavioral coaching and chronic disease management.]]>
      </description>
      <guid>http://www.bioworld.com/articles/722533</guid>
      <pubDate>Mon, 28 Jul 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/722533-trinity-unveils-ai-powered-cgm-biosensor</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/trinity-cgm28july25-2.webp?t=1753740170" type="image/jpeg" medium="image" fileSize="149569">
        <media:title type="plain">Trinity CGM+</media:title>
        <media:description type="plain">Trinity CGM+. Credit: Trinity Biotech</media:description>
      </media:content>
    </item>
    <item>
      <title>Remote patient monitoring shortchanged by Medicare</title>
      <description>
        <![CDATA[A June 25 hearing in the U.S. House of Representatives highlighted some of the health care spending benefits of remote patient monitoring, but Medicare payment is seen as deficient &ndash; a problem that may be resolved by pending legislation.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721226</guid>
      <pubDate>Wed, 25 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721226-remote-patient-monitoring-shortchanged-by-medicare</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/regulatory-washington-capital.webp?t=1588689711" type="image/png" medium="image" fileSize="560021">
        <media:title type="plain">U.S. Capitol building, Washington D.C.</media:title>
      </media:content>
    </item>
    <item>
      <title>Researchers file patent for microfluidic patch-pump drug delivery platform</title>
      <description>
        <![CDATA[Researchers from Virginia Polytechnic Institute and State University filed for protection of their development of a slim, painless, and affordable microfluidic infusion pump device for the continuous transdermal delivery of drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720781</guid>
      <pubDate>Thu, 12 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720781-researchers-file-patent-for-microfluidic-patch-pump-drug-delivery-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/microfluidic-patch-pump-12june25.webp?t=1749759563" type="image/jpeg" medium="image" fileSize="321584">
        <media:title type="plain">microfluidic patch pump</media:title>
        <media:description type="plain">WO2025106990-A1, “Microfluidic patch-pump for delivery of liquid drugs.”Assignee: Virginia Tech Intellectual Properties Inc.Inventors: Staples, Anne; Davalos, Rafael, V.; Zhang, ShuyuIPC codes: A61M 37/00; A61M 5/145Publication date: May 22, 2025Earliest priority details: US2023600540, Nov. 17, 2023</media:description>
      </media:content>
    </item>
    <item>
      <title>MFDS clears world’s first ECG-based AI kidney disease software</title>
      <description>
        <![CDATA[South Korea’s Ministry of Food and Drug Safety on June 9 approved Vuno Inc’s AI-based Med-DeepECG Kidney software as a non-invasive method to screen for kidney dysfunction.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720771</guid>
      <pubDate>Wed, 11 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720771-mfds-clears-worlds-first-ecg-based-ai-kidney-disease-software</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Nephrology/Neprology-healthy-kidneys.webp?t=1745263173" type="image/jpeg" medium="image" fileSize="175840">
        <media:title type="plain">Doctor with illustration of kidneys</media:title>
      </media:content>
    </item>
    <item>
      <title>Hinge Health rings NYSE bell as IPO raises $437M</title>
      <description>
        <![CDATA[Hinge Health Inc.’s flexibility produced big rewards as the digital therapy company for physical rehabilitation finally began trading on the NYSE under the symbol HNGE on May 22 after delaying its IPO twice. Hinge co-founders Daniel Perez and Gabriel Mecklenburg rang the opening bell for the stock exchange to celebrate the offering’s $437 million haul.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720269</guid>
      <pubDate>Thu, 22 May 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720269-hinge-health-rings-nyse-bell-as-ipo-raises-437m</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Businessman-and-IPO-virtual-screen.webp?t=1717791671" type="image/jpeg" medium="image" fileSize="332138">
        <media:title type="plain">Businessman and IPO virtual screen</media:title>
      </media:content>
    </item>
    <item>
      <title>Aktiia SA raises $42M for BP monitoring platform, rebrands to Hilo</title>
      <description>
        <![CDATA[Aktiia SA raised $42 million in an oversubscribed series B funding round and rebranded to Hilo. The funds will be used for product innovation, expansion into new markets and to build out its blood pressure monitoring platform to support enterprise use cases.]]>
      </description>
      <guid>http://www.bioworld.com/articles/719633</guid>
      <pubDate>Tue, 06 May 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719633-aktiia-sa-raises-42m-for-bp-monitoring-platform-rebrands-to-hilo</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Hilo-Band-and-App-6may25.webp?t=1746564203" type="image/jpeg" medium="image" fileSize="106462">
        <media:title type="plain">Hilo Band and mobile app</media:title>
        <media:description type="plain">Hilo Band and mobile app. Credit: Hilo</media:description>
      </media:content>
    </item>
    <item>
      <title>Wearoptimo’s hydration sensor outperforms gold standard tests</title>
      <description>
        <![CDATA[Health care technology company Wearoptimo Ltd. developed a next-generation microwearable sensor that accurately detects hydration levels, outperforming the needle-based gold standard.]]>
      </description>
      <guid>http://www.bioworld.com/articles/719517</guid>
      <pubDate>Tue, 29 Apr 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719517-wearoptimos-hydration-sensor-outperforms-gold-standard-tests</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Wearoptimo-microwearable-29Apr25.webp?t=1745956571" type="image/jpeg" medium="image" fileSize="85785">
        <media:title type="plain">Wearoptimo microwearable hydration sensor</media:title>
        <media:description type="plain">Wearoptimo microwearable hydration sensor. Credit: Wearoptimo</media:description>
      </media:content>
    </item>
    <item>
      <title>Fitbit analysis predicts hospitalizations</title>
      <description>
        <![CDATA[Using step counts and heart rate readings from Google’s Fitbit devices, a machine learning model accurately predicted the risk of hospitalization, a study presented at Heart Rhythm 2025 found. The study used data from participants in the National Institutes of Health’s All of Us research program.  ]]>
      </description>
      <guid>http://www.bioworld.com/articles/719162</guid>
      <pubDate>Mon, 28 Apr 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719162-fitbit-analysis-predicts-hospitalizations</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/9-16-Fitbit-Sense-ECG.webp?t=1600297202" type="image/png" medium="image" fileSize="85631">
        <media:title type="plain">Screen on Fitbit Sense reads "Take heart rhythm assessment"</media:title>
        <media:description type="plain">Fitbit Sense includes an ECG app that enables users to take a spot check reading of their heart that can be analyzed for atrial fibrillation. Credit: Fitbit Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>Sky Labs seeks global expansion of world’s first BP monitor ring</title>
      <description>
        <![CDATA[Sky Labs Inc. CEO and founder Jack Byunghwan Lee reported on plans to greatly expand the market for the company’s blood pressure monitor ring, including seeking regulatory approvals for the CART BP products in the U.S., Europe and Japan.]]>
      </description>
      <guid>http://www.bioworld.com/articles/719393</guid>
      <pubDate>Tue, 22 Apr 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719393-sky-labs-seeks-global-expansion-of-worlds-first-bp-monitor-ring</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Sky-Labs-CART-BP_1_22april25.webp?t=1745355097" type="image/jpeg" medium="image" fileSize="490839">
        <media:title type="plain">Sky Labs CART BP</media:title>
        <media:description type="plain">Sky Labs’ CART BP ring. Credit: Sky Labs</media:description>
      </media:content>
    </item>
    <item>
      <title>Neuranics raises $8M for magnetic sensing technology</title>
      <description>
        <![CDATA[Neuranics Ltd. recently raised $8 million in seed funding which is “extremely important” for the company as it looks to scale its magnetic sensing technology, which detects muscle activity without touching the skin, Noel McKenna, CEO told BioWorld. “The funds will help accelerate our go to market strategy and advance our R&D roadmap,” he said.]]>
      </description>
      <guid>http://www.bioworld.com/articles/719142</guid>
      <pubDate>Wed, 16 Apr 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719142-neuranics-raises-8m-for-magnetic-sensing-technology</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Neuranics-technologies-16apr25.webp?t=1744835980" type="image/jpeg" medium="image" fileSize="478014">
        <media:title type="plain">Neuranics technologies</media:title>
        <media:description type="plain">Neuranics technologies. Credit: Neuranics</media:description>
      </media:content>
    </item>
    <item>
      <title>Patent filed for multiweek, multitarget CGM-like wearable sensor</title>
      <description>
        <![CDATA[Researchers from the University of Cincinnati filed for protection of an electrochemical aptamer-based biosensor technology with improved sensitivity and longevity, which has the potential for monitoring several biomarkers over sustained periods.]]>
      </description>
      <guid>http://www.bioworld.com/articles/718901</guid>
      <pubDate>Thu, 10 Apr 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/718901-patent-filed-for-multiweek-multitarget-cgm-like-wearable-sensor</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/CGM-sensor-10apr25.webp?t=1744315437" type="image/jpeg" medium="image" fileSize="415828">
        <media:title type="plain">CGM sensor</media:title>
        <media:description type="plain">WO2025064505-A1, “Electrochemical affinity biosensors with sensor response dependent on proximity of two or more tags.”Assignee: University of CincinnatiInventors: White, Ryan Jeffrey; Henderickson, Spencer; Heikenfeld, Jason C.; Watkins, Zachary Lee; Deehan, MariaIPC codes: G01N 33/530; G01N 27/327Publication date: Mar. 27, 2025Earliest priority details: US2023539258, Sep. 21, 2023</media:description>
      </media:content>
    </item>
    <item>
      <title>Trio of neuro disease-focused firms highlighted at KIMES 2025</title>
      <description>
        <![CDATA[At the four-day KIMES 2025 exhibition, more than 35,000 products and prototypes were on display. In the clamor, <em>BioWorld</em> engaged with three promising neurological disease-focused companies – Readycure Inc., Neurive Co. Ltd. and Vuno Inc. – that showcased innovative technology for conditions like Alzheimer’s disease and tinnitus at the Seoul-based event.]]>
      </description>
      <guid>http://www.bioworld.com/articles/718208</guid>
      <pubDate>Tue, 25 Mar 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/718208-trio-of-neuro-disease-focused-firms-highlighted-at-kimes-2025</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/KIMES-lede-25mar25.webp?t=1742936523" type="image/jpeg" medium="image" fileSize="660458">
        <media:title type="plain">KIMES 2025</media:title>
      </media:content>
    </item>
    <item>
      <title>Toilets could be the next big health device: Medical Korea 2025</title>
      <description>
        <![CDATA[Seung-min Park, professor at Nanyang Technological University and cofounder of Kanaria Health, is working to manufacture smart bidets that can capture biomarker data from urine and stool automatically and enable continuous monitoring.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717994</guid>
      <pubDate>Thu, 20 Mar 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/717994-toilets-could-be-the-next-big-health-device-medical-korea-2025</link>
    </item>
    <item>
      <title>FDA clears loss-of-pulse detection on Google Pixel Watch 3</title>
      <description>
        <![CDATA[The Apple Watch may be able to alert wearers to heart palpitations, but Google LLC’s Pixel Watch 3 can now detect when a user’s heart stops – and call emergency services. The pulse detection featured received clearance from the U.S. FDA on Feb. 26 and Google plans to make it available on its Pixel Watch 3 starting in March. Pulse detection is already available for watches sold in the U.K. and EU.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717633</guid>
      <pubDate>Fri, 28 Feb 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717633-fda-clears-loss-of-pulse-detection-on-google-pixel-watch-3</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Google-Pixel-Watch-3-28feb25.webp?t=1740783146" type="image/jpeg" medium="image" fileSize="140460">
        <media:title type="plain">Google Pixel Watch 3 Loss-of-pulse</media:title>
        <media:description type="plain">Google Pixel Watch 3 Loss-of-pulse feature. Credit: Courtesy Google LLC.</media:description>
      </media:content>
    </item>
    <item>
      <title>Kestra Medical ups IPO target to $150M</title>
      <description>
        <![CDATA[Reflecting a positive reception in the market, Kestra Medical Technologies Ltd. increased the target haul for its planned IPO from $100 million to between $140 million and $160 million in an S-1 amendment filed Feb. 26. The company will offer 10 million shares at $14 to $16 per share, with the final price to be set the week of Mar. 3, just ahead of the offering date.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717613</guid>
      <pubDate>Wed, 26 Feb 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717613-kestra-ups-ipo-target-to-150m</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Dollar-sign-between-hands.webp?t=1740610521" type="image/jpeg" medium="image" fileSize="123345">
        <media:title type="plain">Dollar sign between hands</media:title>
      </media:content>
    </item>
    <item>
      <title>EEG earpiece predicts seizures up to an hour before onset</title>
      <description>
        <![CDATA[The first patenting from Theta Neurotech Inc. sees the company’s co-founders describe their development of a wearable earpiece that uses an electroencephalography technology and machine learning algorithms to alert epilepsy patients 30 to 60 minutes before they have a seizure.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717168</guid>
      <pubDate>Thu, 20 Feb 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717168-eeg-earpiece-predicts-seizures-up-to-an-hour-before-onset</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/EEG-earpiece-20feb25.webp?t=1740093036" type="image/jpeg" medium="image" fileSize="230890">
        <media:title type="plain">EEG earpiece</media:title>
        <media:description type="plain">WO2025030028-A1, “Wearable device for measurement of brain activity.”Assignee: Theta NeurotechInventors: Pierson, Truman; Hussain, Ali; Fitz, ChristopherIPC codes: A61B 5/00; A61B 5/291; A61B 5/259Publication date: Feb. 6, 2025 (also published as US20250040867-A1)Earliest priority details: US2023229340, Aug. 2, 2023</media:description>
      </media:content>
    </item>
    <item>
      <title>Wearable developed for breast cancer self-examination, detection</title>
      <description>
        <![CDATA[The latest patenting from Canan Dagdeviren seeks protection for their wearable, conformable ultrasound breast patch that enables standardized and reproducible image acquisition over the entire breast with less reliance on operator training and applied transducer compression.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717160</guid>
      <pubDate>Wed, 19 Feb 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717160-wearable-developed-for-breast-cancer-self-examination-detection</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/BC-wearable-19feb25.webp?t=1740002286" type="image/jpeg" medium="image" fileSize="324092">
        <media:title type="plain">BC wearable</media:title>
        <media:description type="plain">WO2025024032-A1, “Conformable ultrasound scanning and imaging methods and apparatus and related techniques.”Assignee: Massachusetts Institute of TechnologyInventors: Dagdeviren, CananIPC codes: A61B 8/08; A61B 8/00; A61B 5/00Publication date: Jan. 30, 2025Earliest priority details: US2023515873, July 27, 2023</media:description>
      </media:content>
    </item>
    <item>
      <title>Ōura closes $200M series D, Dexcom invests $75M</title>
      <description>
        <![CDATA[Dexcom Inc. put real money behind expanding its integration efforts, with a $75 million investment in the $200 million series D for Ōura Health Oy, the maker of the Ōura smart ring. Ōura and Dexcom also provided details on a strategic partnership that integrates data from Dexcom’s continuous glucose monitors with vital sign, sleep, stress, heart health and activity data from the Ōura ring.    ]]>
      </description>
      <guid>http://www.bioworld.com/articles/715224</guid>
      <pubDate>Thu, 19 Dec 2024 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/715224-ura-closes-200m-series-d-dexcom-invests-75m</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2024/Oura-Ring-19dec24.webp?t=1760478501" type="image/jpeg" medium="image" fileSize="394173">
        <media:title type="plain">Oura Ring</media:title>
        <media:description type="plain">Oura ring. Credit: Oura Health Oy</media:description>
      </media:content>
    </item>
    <item>
      <title>Electrocore powers up with Neurometrix acquisition</title>
      <description>
        <![CDATA[Electrocore Inc. Quell(ed) any concerns about its commitment to the bioelectronic health segment with an agreement to acquire Neurometrix Inc., maker of the Quell, a wearable device and cloud-enabled neuromodulation platform to treat fibromyalgia and lower extremity chronic pain. Neurometrix is expected to divest its other primary product, Dpncheck, a point-of-care screening test for diabetic peripheral neuropathy, prior to the acquisition.]]>
      </description>
      <guid>http://www.bioworld.com/articles/715213</guid>
      <pubDate>Wed, 18 Dec 2024 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/715213-electrocore-powers-up-with-neurometrix-acquisition</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Acquisition-puzzle.webp?t=1682968589" type="image/jpeg" medium="image" fileSize="193595">
        <media:title type="plain">Acquisition puzzle</media:title>
      </media:content>
    </item>
    <item>
      <title>UK researchers develop Pneumorator, a wearable respiratory sensor</title>
      <description>
        <![CDATA[U.K. researchers at Nottingham Trent University, the University of Southampton and University Hospital Southampton and product development company Zelemiq Ltd. developed a wearable sensor that accurately monitors and detects changes in people’s breathing without requiring direct contact with the skin.]]>
      </description>
      <guid>http://www.bioworld.com/articles/715108</guid>
      <pubDate>Thu, 12 Dec 2024 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/715108-uk-researchers-develop-pneumorator-a-wearable-respiratory-sensor</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2024/Pneumorator-12dec24.webp?t=1734044172" type="image/jpeg" medium="image" fileSize="309087">
        <media:title type="plain">Pneumorator</media:title>
        <media:description type="plain">The Pneumorator wireless, contactless respiratory sensor.</media:description>
      </media:content>
    </item>
  </channel>
</rss>
